MINOCA: under recognized and affecting predominantly female patients-an Australian experience.

Lung En TengSaadat SaleemiManuja Premaratne

Published in: Irish journal of medical science (2022)

The clinical prevalence rate of MINOCA at Peninsula Health is 10.9% with a MACE of 5.2%. MINOCA is recognized and the low rate of additional testing could be improved given the female predominance and prognostic implications.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
risk factors
mental health
prognostic factors
health information
risk assessment